Pain News and Research

Latest Pain News and Research

Severe skin reactions during radiation therapy could be prevented by applying silicone dressing

Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of treatment, clinical research from New Zealand shows.

13 Feb 2014

Researchers examine quality of needles used in acupuncture

The quality of needles used in acupuncture worldwide is high but needs to be universally improved to increase safety and avoid potential problems such as pain and allergic reactions, RMIT University researchers have found.

13 Feb 2014

New technology to enhance angioplasty with added precision, accuracy and less radiation exposure

Robots in the cath lab are helping clear blocked arteries in patients — reducing chest pain, shortness of breath, and risks for heart attacks. The Orlando Health Heart Institute is the first in the state of Florida, to offer a robotic-assisted system for coronary angioplasty.

13 Feb 2014

Adolescents with psychiatric problems more likely to suffer chronic pain

For the first time researchers have studied the kind of physical pain that troubles adolescents with different mental health problems.

12 Feb 2014

FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

InControl Medical, LLC, a women's health company focusing on female urinary incontinence, has received FDA clearance for their proprietary, patented, InToneMV, providing women who suffer with vaginal atrophy a smaller, more comfortable medical device for the treatment of stress, urge and mixed female urinary incontinence without surgery or drugs.

12 Feb 2014

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.

11 Feb 2014

Surgeons now use minimally invasive robotic surgical system for Whipple procedure

The Whipple procedure, used to remove tumors from pancreatic cancer patients, is one of surgery's most extensive and challenging operations.

11 Feb 2014

Athletic scholarships could lead to long-term health consequences, warns Loyola sports medicine physician

College athletes are putting themselves at risk for health problems that could persist long after they graduate, warns Loyola University Medical Center sports medicine physician Dr. Pietro Tonino.

11 Feb 2014

Alba Therapeutics reports positive results from Phase IIb trial of larazotide acetate for CeD treatment

Alba Therapeutics Corporation announced today the positive results of their Phase IIb trial evaluating its investigational product, larazotide acetate, a first-in-class tight junction regulator, intended for the treatment of patients with celiac disease (CeD).

11 Feb 2014

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.

11 Feb 2014

Body regulates hormone crucial for motivation and stress response, reveals research

New research has revealed a previously unknown mechanism in the body which regulates a hormone that is crucial for motivation, stress responses and control of blood pressure, pain and appetite. The breakthrough could be used to design drugs to help fight health problems connected with these functions in the future.

11 Feb 2014

Researchers shed new light on pain associated with bacterial infections

Components in the outer wall of bacteria directly activate pain sensors, triggering immediate pain and inflammatory responses. This finding by a multinational team of researchers led by Professor Karel Talavera (KU Leuven, Belgium) and Professor Félix Viana (Institute of Neuroscience, Spain) sheds new light on pain associated with bacterial infections and reveals a new target for drugs designed to treat them.

11 Feb 2014

Mallinckrodt announces commercial launch of PENNSAID

Mallinckrodt today announced the commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.

10 Feb 2014

Sarepta Therapeutics reports positive safety results from AVI-7288 Phase I study

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced positive safety results from a Phase I multiple ascending dose study of AVI-7288 in healthy volunteers.

10 Feb 2014

NASA signs patent to develop novel biotechnology approaches that could have medical applications

NASA has signed two patent license agreements with GRoK Technologies LLC of Houston to help develop novel biotechnology approaches that could have multiple applications in space and on Earth.

10 Feb 2014

Women who survive stroke have worse quality of life than men

The good news: More people survive stroke now than 10 years ago due to improved treatment and prevention.

10 Feb 2014

Telephone communication in IBD care helps to identify patients at risk of high-cost medical interventions

A comprehensive analysis of patient telephone records at an inflammatory bowel disease (IBD) clinic revealed that 15 percent of patients account for half of all calls to the clinic. Forty-two percent of frequent-caller patients also were seen in the emergency department or hospitalized within the following year.

10 Feb 2014

New method to build tiny degradable 'medicine factories' inside the body

A factory built of gel does not sound very durable. But the new type of micro-factories invented by researchers at Aarhus University do not have to last.

9 Feb 2014

Spinifex announces results of Phase 2 clinical trial of EMA401 in postherpetic neuralgia

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces that The Lancet has published the results of its Phase 2 clinical trial of its lead candidate, EMA401, in postherpetic neuralgia (PHN).

5 Feb 2014

New MRI can predict which atrial fibrillation patients are most likely to benefit from catheter ablation

A new type of contrast MRI can predict which heart patients with atrial fibrillation are most likely to benefit from a treatment called catheter ablation, according to a landmark multi-center study published in the Journal of the American Medical Association.

5 Feb 2014

Pain News and Research

Latest Pain News and Research

Severe skin reactions during radiation therapy could be prevented by applying silicone dressing

Researchers examine quality of needles used in acupuncture

New technology to enhance angioplasty with added precision, accuracy and less radiation exposure

Adolescents with psychiatric problems more likely to suffer chronic pain

FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Surgeons now use minimally invasive robotic surgical system for Whipple procedure

Athletic scholarships could lead to long-term health consequences, warns Loyola sports medicine physician

Alba Therapeutics reports positive results from Phase IIb trial of larazotide acetate for CeD treatment

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Body regulates hormone crucial for motivation and stress response, reveals research

Researchers shed new light on pain associated with bacterial infections

Mallinckrodt announces commercial launch of PENNSAID

Sarepta Therapeutics reports positive safety results from AVI-7288 Phase I study

NASA signs patent to develop novel biotechnology approaches that could have medical applications

Women who survive stroke have worse quality of life than men

Telephone communication in IBD care helps to identify patients at risk of high-cost medical interventions

New method to build tiny degradable 'medicine factories' inside the body

Spinifex announces results of Phase 2 clinical trial of EMA401 in postherpetic neuralgia

New MRI can predict which atrial fibrillation patients are most likely to benefit from catheter ablation

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Pain News and Research

Latest Pain News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in